BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT

Clinical trial NCT02670252 · COMPLETED

Trial details

NCT number: NCT02670252
Sponsor: Nanfang Hospital, Southern Medical University
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Allogeneic Hematopoietic Stem Cell Transplantation Busulfan Total Body Irradiation Acute Lymphocytic Leukemia

Start date: 2016-01-01
Primary completion: 2020-02-01
Enrollment: 550

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.